ESPR logo
ESPR

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. (ESPR) Earnings

Last reported
March 31, 2026
EPS Miss · -192.4%
EPS estimate
-$0.03
EPS actual
-$0.10
Revenue est.
Revenue actual